Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Scientific Reports|October 28, 2017
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer ModelKayla F Goliwas, Jillian R Richter, Hawley C Pruitt, et al.
Oncogene|June 18, 2013
Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signalingD J Devine, J W Rostas, B J Metge, et al.
Scientific Reports|January 24, 2017
Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signalingShamik Das, William P Jackson, Jeevan K Prasain, et al.
International Journal of Legal Medicine|July 9, 2008
The Microbial Rosetta Stone: a database system for tracking infectious microorganismsKumar L Hari, Alan T Goates, Ravi Jain, et al.
Biochemical and Biophysical Research Communications|August 22, 2006
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperoneDouglas R Hurst, Alka Mehta, Blake P Moore, et al.
Cell Death & Disease|March 5, 2021
Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancerShannon E Weeks, Sarah C Kammerud, Brandon J Metge, et al.
Cancer Letters|May 30, 2021
Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seedingHeba Allah M Alsheikh, Brandon J Metge, Chae-Myeong Ha, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of niclosamide on basal-like breast cancersAngelina I Londoño-Joshi, Rebecca C Arend, Laura Aristizabal, et al.
Molecular Cell|August 25, 2023
A hierarchical assembly pathway directs the unique subunit arrangement of TRiC/CCTKaren Betancourt Moreira, Miranda P Collier, Alexander Leitner, et al.
Pageof 21